Excimer & Femtosecond Ophthalmic Lasers Market Opportunity 2028

report image

Excimer & Femtosecond Ophthalmic Lasers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Excimer Laser and Femtosecond Laser), Application (Refractive Surgery, Cataract Surgery, Capsulotomy, Trabeculoplasty, and Diagnostics), and End User (Hospitals, Ambulatory Surgical Centers, and Ophthalmology Clinics)

Publication Month: Oct 2021 | Report Code: TIPRE00007730 | No. of Pages: 177 | Category: Medical Device | Status: Published

The excimer & femtosecond ophthalmic lasers market is expected to reach US$ 1,118.64 million by 2028 from US$ 795.68 million in 2021; it is estimated to grow at a CAGR of 5.0% during 2021 to 2028.

The laser technology is used in many medical disciplines and specialties, and it plays an important role in promoting ophthalmology advancement, especially corneal refractive surgery. Ophthalmology laser is of two types such as excimer laser, photorefractive keratectomy (PRK), laser epithelial keratomileusis (LASEK), epipolis laser in situ keratomileusis (Epi-LASIK), and transepithelial photorefractive keratectomy (Trans-PRK) and presbyopia surgery) and femtosecond laser such as femtosecond laser in situ keratomileusis (FS-LASIK), insertion of intracorneal ring segments, small-incision lenticule extraction (SMILE), and femtosecond lenticule extraction (Flex).


Report Coverage


The growth of the excimer & femtosecond ophthalmic lasers market is attributed to the factors such as a rise in elderly population, and increase in the number of cataract and refractive surgeries. However, the high cost of ophthalmology surgeries and devices hampers the growth of the market.


Lucrative Regions for Excimer & Femtosecond Ophthalmic Lasers Market

Lucrative Regions for Excimer & Femtosecond Ophthalmic Lasers Market

Get more information on this report :


Market Insights

Significant Rise in Elderly Population

Rise in geriatric population in countries such as the US, the UK, Canada, Japan, China, India, and South Korea is driven by the modernization of healthcare facilities and improvements in healthcare services, which boosts the life expectancy in these countries. According to the data by the WHO in February 2018, the geriatric population is estimated to rise from 12% in 2015 to 22% by 2050. According to the US Census Bureau, the number of people in the US with age 65 and above is anticipated to grow from 46 million in 2016 to more than 98 million by 2060, while their population share would grow from ~15% to ~24% during this period. As per the United Nation’s World Population Ageing 2017 report, in 2017, Europe had the world’s highest percentage (i.e., 25%) of people aged more than 60 years. Further, by 2050, all regions of the world, except Africa, would have ~25% or more of their populations aged 60 and above, and underdeveloped and developing countries would account for ~80% of this growth.

The loss of vision is a major health problem among the elderlies. Age-related macular degeneration, glaucoma, cataracts, and diabetic retinopathy are among the most common causes of vision loss among people from this age group. Age-related macular degeneration results in the loss of central vision. Optic nerve injury and visual field loss can occur as a result of primary open-angle glaucoma. As this ailment can be asymptomatic at first, elderly people need regular check-ups. Although cataracts are the common source of visual issues in these people. However, cataracts can usually be removed through surgical procedures. Diabetic retinopathy is also common among older people during the early stages of diabetes or at the time of diagnosis. A mydriatic examination is recommended when a patient is diagnosed with diabetes, followed by once a year visit thereafter.

According to the American Institute of Ophthalmology, ~24.4 million people of age below 40 undergo cataract surgery, and ~5% of all Americans undergo cataract surgery by the age of 75. Furthermore, glaucoma cases are on the rise, and the condition affects over 2.7 million Americans of age 40 and above. New eye diseases, such as age-related macular degeneration, which affects over 2.1 million Americans of age 50 and above, can cause serious vision loss. Thus there is a significantly high adoption of new technologies, such as femtosecond lasers, in cataract surgery, which involves a large upfront investment but promises improvements in patient outcomes. Thus, the rise in geriatric population fuels the growth of the excimer & femtosecond ophthalmic lasers market.

Product Type -Based Insights

Based on product type, the excimer & femtosecond ophthalmic lasers market is segmented into excimer laser and femtosecond laser. The femtosecond laser segment is expected to lead the market in 2021, and it is expected to retain its dominance during 2021–2028. In addition, the same segment is also expected to grow at the fastest rate during the coming years.

Excimer & Femtosecond Ophthalmic Lasers Market, by Product Type – 2021 and 2028

Excimer & Femtosecond Ophthalmic Lasers Market, by Product Type – 2021 and 2028

Get more information on this report :

Application-Based Insights

Based on application, the excimer & femtosecond ophthalmic lasers market is segmented into refractive surgery, cataract surgery, capsulotomy, trabeculoplasty, and diagnostics. The refractive surgery segment is projected to hold the largest share of the market in 2021, whereas the cataract surgery segment is estimated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the excimer & femtosecond ophthalmic lasers market is segmented into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospitals segment is estimated to hold the largest share of the market in 2021. However, the ophthalmic clinics segment is estimated to register the highest CAGR in the market during the forecast period.  

Strategic Insights

Report Coverage - Excimer & Femtosecond Ophthalmic Lasers Market
Report CoverageDetails
Market Size Value inUS$ 795.68 million in 2021`
Market Size Value byUS$ 1,118.64 million by 2028
Growth rateCAGR of 5.0% from 2021-2028
Forecast Period2021-2028
Base Year2021
No. of Pages177
No. of Tables84
No. of Charts & Figures72
Historical data availableYes
Segments coveredProduct Type, Application, and End User
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Companies in the excimer & femtosecond ophthalmic lasers market focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

Excimer & Femtosecond Ophthalmic Lasers Market – by Product Type

  • Femtosecond Laser
  • Excimer Laser

Excimer & Femtosecond Ophthalmic Lasers Market – by Application  

  • Refractive Surgery
  • Cataract Surgery
  • Capsulotomy
  • Trabeculoplasty
  • Diagnostics

Excimer & Femtosecond Ophthalmic Lasers Market – by End User    

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Excimer & Femtosecond Ophthalmic Lasers Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Bausch Health Companies Inc.
  • Alcon Inc.
  • ZEISS International
  • NIDEK CO., LTD
  • IVIS TECHNOLOGIES
  • EXCELSIUS MEDICAL GMBH
  • Ziemer Ophthalmic Systems
  • SCHWIND EYE-TECH-SOLUTIONS
  • LENSAR, Inc.
  • NKT Photonics A/S

Frequently Asked Questions

Hospitals, ambulatory surgical centers, and ophthalmology clinics are key end users of excimer & femtosecond ophthalmic lasers. Hospitals offer various treatments for different eye conditions. An ophthalmologist in these hospitals treats thousands of patients with a wide variety of eye conditions. Thus, the hospitals segment led the market in 2021 and is expected to retain its dominance during the forecast period.
The refractive surgery segment dominated the global excimer & femtosecond ophthalmic lasers market and held the largest revenue share in 2021. However, the cataract surgery segment is expected to grow at the fastest rate during the coming years.
Excimer Laser eye surgery is a treatment to correct nearsightedness, farsightedness, or astigmatism. The surgery reduces or eliminates the need to wear contact lenses or glasses. In this surgery, the rays of invisible ultraviolet light from the excimer laser remove a minimal quantity of tissue from the cornea to correct the curvature. This process is known as photo ablative decomposition.
Similarly, a femtosecond laser, an infrared laser, emits bursts of laser energy at a high-speed rate. A femtosecond laser has a pulse span in the femtosecond range or one quadrillionth of a second. Femtosecond Lasers are widely used for cataract surgery. The U.S. Federal Drug Administration (FDA) approved Femtosecond Lasers Assisted Cataract Surgery (FLACS) in 2010. According to the WHO, cataract is the leading cause of blindness globally, and nearly 18 million people are bilaterally blind from cataract.
Factors such as the significant rise in elderly population and increase in the number of cataract and refractive surgeries are driving the market growth.
The excimer & femtosecond ophthalmic lasers market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the US holds the largest size of the excimer & femtosecond ophthalmic lasers market. North America held a prominent position in the global market due to growing healthcare expenditure in the US and the development of world-class healthcare infrastructure. Further, the growing prevalence of ophthalmic disorders is anticipated to underpin the demand for these products in the regions. The Asia Pacific region is expected to account for the fastest growth in the excimer & femtosecond ophthalmic lasers market. The market in the Asia Pacific region is expected to grow at a quicker pace due to factors such as rapid growth in the geriatric population, the rise in healthcare awareness about the importance of eye health, and the increase in the number of cataracts refractive surgeries.
The excimer & femtosecond ophthalmic lasers market majorly consists of the players such as Bausch Health Companies Inc., Alcon Inc., ZEISS International, NIDEK CO., LTD, IVIS TECHNOLOGIES, EXCELSIUS MEDICAL GMBH, Ziemer Ophthalmic Systems, SCHWIND EYE-TECH-SOLUTIONS, LENSAR, Inc., and NKT Photonics A/S among others.

The List of Companies - Excimer & Femtosecond Ophthalmic Lasers Market

  1. Bausch Health Companies Inc.
  2. Alcon Inc.
  3. ZEISS International
  4. NIDEK CO., LTD
  5. IVIS TECHNOLOGIES
  6. EXCELSIUS MEDICAL GMBH
  7. Ziemer Ophthalmic Systems
  8. SCHWIND EYE-TECH-SOLUTIONS
  9. LENSAR, Inc.
  10. NKT Photonics A/S
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the excimer & femtosecond ophthalmic lasers market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global excimer & femtosecond ophthalmic lasers market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00007730
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount